ID17088A - Tablet galantamin hidrobromida yang sangat mudah larut - Google Patents

Tablet galantamin hidrobromida yang sangat mudah larut

Info

Publication number: ID17088A
Authority: ID; Indonesia
Prior art keywords: galantamin; hydrobromides; tablet; easy solutions; solutions
Prior art date: 1996-06-14

Application number

IDP972025A

Other languages

English (en)

Inventor

Paul Marie Victor Gilis

Valentin Florent Victor Conde

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-14

Filing date

1997-06-13

Publication date

1997-12-04

1997-06-13 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1997-12-04 Publication of ID17088A publication Critical patent/ID17088A/id

Links

229960003980 galantamine Drugs 0.000 title 1
ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Addiction (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IDP972025A 1996-06-14 1997-06-13 Tablet galantamin hidrobromida yang sangat mudah larut ID17088A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP96201676		1996-06-14

Publications (1)

Publication Number	Publication Date
ID17088A true ID17088A (id)	1997-12-04

Family

ID=8224084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP972025A ID17088A (id)	1996-06-14	1997-06-13	Tablet galantamin hidrobromida yang sangat mudah larut

Country Status (32)

Country	Link
US (2)	US6099863A (id)
EP (1)	EP0915701B1 (id)
JP (1)	JP4172820B2 (id)
KR (1)	KR100358676B1 (id)
CN (1)	CN1102390C (id)
AR (2)	AR008237A1 (id)
AT (1)	ATE285777T1 (id)
AU (1)	AU726212B2 (id)
BG (1)	BG64168B1 (id)
BR (1)	BR9709729A (id)
CA (1)	CA2257431C (id)
CZ (1)	CZ295226B6 (id)
DE (1)	DE69732113T2 (id)
DK (1)	DK0915701T3 (id)
EA (1)	EA001193B1 (id)
EE (1)	EE03337B1 (id)
ES (1)	ES2235234T3 (id)
HR (1)	HRP970321B1 (id)
ID (1)	ID17088A (id)
IL (1)	IL127519A (id)
MY (1)	MY121669A (id)
NO (1)	NO322892B1 (id)
NZ (1)	NZ333280A (id)
PL (1)	PL189329B1 (id)
PT (1)	PT915701E (id)
SI (1)	SI0915701T1 (id)
SK (1)	SK284620B6 (id)
TR (1)	TR199802592T2 (id)
TW (1)	TW506836B (id)
UA (1)	UA62930C2 (id)
WO (1)	WO1997047304A1 (id)
ZA (1)	ZA975281B (id)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6440457B1 (en) *	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
US8071128B2 (en)	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
TW506836B (en) *	1996-06-14	2002-10-21	Janssen Pharmaceutica Nv	Fast-dissolving galanthamine hydrobromide tablet
ATE252386T1 (de) *	1998-12-24	2003-11-15	Janssen Pharmaceutica Nv	Galantamin-zusammensetzung mit gesteuerter freisetzung
US20050063998A1 (en) *	1999-10-26	2005-03-24	Francois Marc Karel Jozef	Oral solution containing galantamine and a sweetening agent
US6627223B2 (en) *	2000-02-11	2003-09-30	Eurand Pharmaceuticals Ltd.	Timed pulsatile drug delivery systems
CA2406383A1 (en) *	2000-04-13	2001-10-25	Mayo Foundation For Medical Education And Research	A.beta.42 lowering agents
SE521512C2 (sv) *	2001-06-25	2003-11-11	Niconovum Ab	Anordning för administrering av en substans till främre delen av en individs munhåla
US6500454B1 (en) *	2001-10-04	2002-12-31	Eurand Pharmaceuticals Ltd.	Timed, sustained release systems for propranolol
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
MXPA04009535A (es) *	2002-04-02	2005-01-25	Janssen Pharmaceutica Nv	Terapia con estatina para mejorar el mantenimiento cognoscitivo.
DE10235556A1 (de) *	2002-08-03	2004-02-19	Hf Arzneimittelforschung Gmbh	Medikament und Verfahren zur Verringerung des Alkohol- und/oder Tabakkonsums
US20040097484A1 (en) *	2002-11-14	2004-05-20	Marc Cantillion	Once a day galantamine pharmaceutical compositions and methods of use
EP3473251B1 (en)	2002-12-20	2023-12-13	NicoNovum AB	A nicotine-cellulose combination
US8367111B2 (en)	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
EP1603548A4 (en) *	2003-02-05	2007-10-10	Myriad Genetics Inc	METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
US7521481B2 (en) *	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
DE10338544B4 (de) *	2003-08-19	2017-08-31	Janssen Pharmaceutica N.V.	Buccale Formulierungen des Galanthamins und deren Anwendungen
MXPA06002257A (es) *	2003-08-26	2006-05-17	Shire Holdings Ag	Farmaceutica que comprende compuestos de lantano.
US20050143350A1 (en) *	2003-11-19	2005-06-30	Seed John C.	Combination drug therapy to treat obesity
WO2005051489A2 (en) *	2003-11-28	2005-06-09	Ranbaxy Laboratories Limited	Fast dissolving solid oral dosage forms of galanthamine
EP2340813A1 (en) *	2003-12-31	2011-07-06	Actavis Group PTC ehf.	Solid dosage formulations of galantamine
WO2005065662A1 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Solid dosage formulations of galantamine
EP1763337A2 (en) *	2003-12-31	2007-03-21	Actavis Group HF	Immediate, controlled and sustained release formulations of galanthamine
WO2006020852A2 (en) *	2004-08-11	2006-02-23	Myriad Genetics, Inc.	Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) *	2004-08-11	2006-02-23	Myriad Genetics, Inc.	Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) *	2004-08-11	2006-02-23	Myriad Genetics, Inc.	Pharmaceutical composition and method for treating neurodegenerative disorders
US8747895B2 (en)	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
ES2519690T3 (es) *	2004-09-24	2014-11-07	University Of Maryland, Baltimore	Método de tratamiento de envenenamiento por organosfósforo
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
ES2409347T3 (es)	2004-10-21	2013-06-26	Aptalis Pharmatech, Inc.	Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
ATE439347T1 (de) *	2004-11-23	2009-08-15	Warner Lambert Co	7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
US20080145422A1 (en) *	2005-02-10	2008-06-19	Roxane Laboratories, Inc.	Galantamine tablet formulation
US9161918B2 (en) *	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
GB0516604D0 (en) *	2005-08-12	2005-09-21	Sandoz Ag	Rapidly dispersing/disintegrating compositions
US8168219B2 (en) *	2005-11-30	2012-05-01	Isp Investments Inc.	Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability
CA2646942C (en)	2006-03-16	2014-07-29	Modoral Brands Inc.	Improved snuff composition
SI2010158T1 (sl) *	2006-04-26	2016-08-31	Alphapharm Pty Ltd.	Nadzorovane formulacije sproščanja obsegajoče neoplaščeno(e) diskretno(e) enoto(e) in razširjena matrika sproščanja
GB0612540D0 (en) *	2006-06-23	2006-08-02	Novartis Ag	Galenical formulations of organic compounds
EP2043613A1 (en) *	2006-07-14	2009-04-08	Fmc Corporation	Solid form
CN100438917C (zh) *	2006-07-20	2008-12-03	山东聊城阿华制药有限公司	一种微晶纤维素乳糖的制备方法
WO2008062426A2 (en) *	2006-08-02	2008-05-29	Emcure Pharmaceuticals Limited	Formulation of benzazepine derivatives
SG178000A1 (en)	2006-10-27	2012-02-28	Medivation Neurology Inc	Methods and combination therapies for treating alzheimer's disease
US20080311162A1 (en) *	2007-05-16	2008-12-18	Olivia Darmuzey	Solid form
UY31531A1 (es) *	2007-12-17	2009-08-03		Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
EP2116232B1 (de)	2008-05-09	2012-02-15	Ratiopharm GmbH	Galanthaminhaltiges Arzneimittel mit kontrollierter Freisetzung
RU2563623C2 (ru)	2009-12-02	2015-09-20	Апталис Фарма Лимитед	Микрокапсулы фексофенадина и содержащие их композиции
WO2011151359A1 (en)	2010-06-02	2011-12-08	Noscira, S.A.	Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
JP5656258B2 (ja) *	2011-03-09	2015-01-21	塩野義製薬株式会社	ガランタミンを含有する口腔内崩壊錠剤
CA2921308A1 (en)	2013-08-16	2015-02-19	Universiteit Maastricht	Treatment of cognitive impairment with pde4 inhibitor
CN106822008A (zh) *	2017-01-11	2017-06-13	江苏艾兰得营养品有限公司	一种维生素d速溶制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3506276C1 (de) *	1985-02-22	1986-04-24	Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring	Direkttablettiermittel
US4663318A (en) *	1986-01-15	1987-05-05	Bonnie Davis	Method of treating Alzheimer's disease
US6150354A (en) *	1987-01-15	2000-11-21	Bonnie Davis	Compounds for the treatment of Alzheimer's disease
US5336675A (en) *	1991-05-14	1994-08-09	Ernir Snorrason	Method of treating mania in humans
JP3291730B2 (ja) *	1991-05-14	2002-06-10	エルニアスノラソン	疲労症候群の治療
TW506836B (en) *	1996-06-14	2002-10-21	Janssen Pharmaceutica Nv	Fast-dissolving galanthamine hydrobromide tablet

1997
- 1997-05-19 TW TW086106622A patent/TW506836B/zh not_active IP Right Cessation
- 1997-06-06 NZ NZ333280A patent/NZ333280A/en not_active IP Right Cessation
- 1997-06-06 EE EE9800429A patent/EE03337B1/xx unknown
- 1997-06-06 DK DK97927159T patent/DK0915701T3/da active
- 1997-06-06 KR KR10-1998-0709401A patent/KR100358676B1/ko not_active Expired - Lifetime
- 1997-06-06 AU AU31743/97A patent/AU726212B2/en not_active Expired
- 1997-06-06 JP JP50118198A patent/JP4172820B2/ja not_active Expired - Lifetime
- 1997-06-06 SI SI9730690T patent/SI0915701T1/xx unknown
- 1997-06-06 WO PCT/EP1997/002986 patent/WO1997047304A1/en not_active Ceased
- 1997-06-06 CA CA002257431A patent/CA2257431C/en not_active Expired - Lifetime
- 1997-06-06 PL PL97330431A patent/PL189329B1/pl unknown
- 1997-06-06 CZ CZ19984034A patent/CZ295226B6/cs not_active IP Right Cessation
- 1997-06-06 UA UA98126372A patent/UA62930C2/uk unknown
- 1997-06-06 BR BR9709729A patent/BR9709729A/pt not_active IP Right Cessation
- 1997-06-06 EA EA199900026A patent/EA001193B1/ru not_active IP Right Cessation
- 1997-06-06 US US09/202,187 patent/US6099863A/en not_active Expired - Lifetime
- 1997-06-06 IL IL12751997A patent/IL127519A/en not_active IP Right Cessation
- 1997-06-06 ES ES97927159T patent/ES2235234T3/es not_active Expired - Lifetime
- 1997-06-06 EP EP97927159A patent/EP0915701B1/en not_active Expired - Lifetime
- 1997-06-06 SK SK1696-98A patent/SK284620B6/sk not_active IP Right Cessation
- 1997-06-06 CN CN97195512A patent/CN1102390C/zh not_active Expired - Lifetime
- 1997-06-06 TR TR1998/02592T patent/TR199802592T2/xx unknown
- 1997-06-06 PT PT97927159T patent/PT915701E/pt unknown
- 1997-06-06 AT AT97927159T patent/ATE285777T1/de active
- 1997-06-06 DE DE69732113T patent/DE69732113T2/de not_active Expired - Lifetime
- 1997-06-11 HR HR970321A patent/HRP970321B1/xx not_active IP Right Cessation
- 1997-06-12 MY MYPI97002621A patent/MY121669A/en unknown
- 1997-06-13 ZA ZA975281A patent/ZA975281B/xx unknown
- 1997-06-13 AR ARP970102615A patent/AR008237A1/es active IP Right Grant
- 1997-06-13 ID IDP972025A patent/ID17088A/id unknown
1998
- 1998-12-04 BG BG102991A patent/BG64168B1/bg unknown
- 1998-12-11 NO NO19985815A patent/NO322892B1/no not_active IP Right Cessation
2000
- 2000-06-01 US US09/585,122 patent/US6358527B1/en not_active Expired - Lifetime
2008
- 2008-11-25 AR ARP080105111A patent/AR070670A2/es unknown

Also Published As

Publication number	Publication date
EA199900026A1 (ru)	1999-06-24
NO985815D0 (no)	1998-12-11
JP2000511918A (ja)	2000-09-12
AR070670A2 (es)	2010-04-28
US6358527B1 (en)	2002-03-19
KR20000015851A (ko)	2000-03-15
NO985815L (no)	1998-12-11
PT915701E (pt)	2005-05-31
AU3174397A (en)	1998-01-07
EA001193B1 (ru)	2000-12-25
ZA975281B (en)	1998-12-14
IL127519A (en)	2002-07-25
BR9709729A (pt)	1999-08-10
SI0915701T1 (en)	2005-06-30
AU726212B2 (en)	2000-11-02
HK1019703A1 (en)	2000-02-25
PL189329B1 (pl)	2005-07-29
KR100358676B1 (ko)	2003-02-17
ES2235234T3 (es)	2005-07-01
EE03337B1 (et)	2001-02-15
CN1222077A (zh)	1999-07-07
SK169698A3 (en)	1999-10-08
EP0915701B1 (en)	2004-12-29
NZ333280A (en)	1999-09-29
AR008237A1 (es)	1999-12-29
CZ295226B6 (cs)	2005-06-15
JP4172820B2 (ja)	2008-10-29
EP0915701A1 (en)	1999-05-19
MY121669A (en)	2006-02-28
SK284620B6 (sk)	2005-07-01
DK0915701T3 (da)	2005-04-25
PL330431A1 (en)	1999-05-10
ATE285777T1 (de)	2005-01-15
WO1997047304A1 (en)	1997-12-18
HRP970321A2 (en)	1998-04-30
NO322892B1 (no)	2006-12-18
UA62930C2 (uk)	2004-01-15
TR199802592T2 (xx)	1999-03-22
CA2257431C (en)	2001-11-20
DE69732113T2 (de)	2005-12-08
CN1102390C (zh)	2003-03-05
BG102991A (en)	1999-08-31
CA2257431A1 (en)	1997-12-18
DE69732113D1 (de)	2005-02-03
HRP970321B1 (en)	2001-12-31
CZ403498A3 (cs)	1999-03-17
IL127519A0 (en)	1999-10-28
BG64168B1 (bg)	2004-03-31
TW506836B (en)	2002-10-21
US6099863A (en)	2000-08-08

Publication	Publication Date	Title
ID17088A (id)	1997-12-04	Tablet galantamin hidrobromida yang sangat mudah larut
NO985499D0 (no)	1998-11-25	Likestr°mstransformator/reaktor
ID26334A (id)	2000-12-14	Morfolinol yang aktif secara farmasi
ID28110A (id)	2001-05-03	Surfaktan alkilbenzenasulfonat yang disempurnakan
NO975894L (no)	1998-06-15	Foringsr°rpakning
NO984316D0 (no)	1998-09-17	Skjµreverkt°y
DE69716101D1 (de)	2002-11-07	Wasserundurchlässige gesichtsmaske
DE69739919D1 (de)	2010-08-05	Polyelektrolyt
DE59707194D1 (de)	2002-06-13	Direkttablettierhilfsmittel
ID29629A (id)	2001-09-06	Tablet yang lapas-segera
DK0966287T3 (da)	2003-08-25	Oxacarbazepinfilmovertrukne tabletter
NO303590B1 (no)	1998-08-03	L°pehjul
DK0812808T3 (da)	2003-12-22	Vandblødgøringstabletter
NO990552D0 (no)	1999-02-05	Innrettingsverkt°y
NO973953D0 (no)	1997-08-28	Sprinklersystem
ID21770A (id)	1999-07-22	Plester yang mengandung felbinak
NO305650B1 (no)	1999-07-05	L°ftejekk
NO985395D0 (no)	1998-11-19	L°fteanordning
NO992852D0 (no)	1999-06-11	Basisstr°mningsenhet
ATA198296A (de)	1998-12-15	Peltonrad - vorspannung
NO964898D0 (no)	1996-11-18	Elektrokjemisk anlegg
DE69624511D1 (de)	2002-11-28	Umkehrbares pumpe-turbine system
DK0943225T3 (da)	2001-08-13	Strømforsyning til mikrofon
DE59804973D1 (de)	2002-09-05	Rundlauf-Tablettenpresse
KR980000948U (ko)	1998-03-30	블록 놀이 기구